Zagazig University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Zagazig Egypt (1974)

Organization Overview

First Clinical Trial
2011
NCT03193775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Anesthesia and Surgical Intensive Care Department, faculty of medicine, Zagazig University | Anesthesia and Surgical Intensive Care Department, Faculty of Medicine, Zagazig University | Anesthesia and surgical intensive care, zagazig university, faculty of medicine | Armed Forces Hospitals Southern Region | Assistant prof of medicine-Zagazig University | Ayman Magd Eldin Mohammad Sadek | Department of Community Medicine and Public Health, Faculty of Medicine, Zagazig University | Essam Fathi | Faculty of Human medicine, Zagazig university | faculty of medicine - Zagazig university | faculty of medicine , Zagazig university | faculty of medicine , Zagazig University | Faculty of Medicine- Zagazig university | Faculty of Medicine, Zagazig University | FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY | Faculty of medicine,Zagazig university,Egypt | Faculty of medicine,Zagazig University,Egypt | Faculty of Medicine, Zagazig University , Zagazig, Egypt | Faculty of Medicine, Zagazig University, Zagazig, Egypt. | Faculty of medicine, zagazig university, Zagazig, Elsharqya, Egypt, 44519 | FAlbasri | Hepatology unit - Zagazig University | Laylay Mohammed Khalleefah Alhibshi | Mohamed Mahmoud Dohiem | Radiology Dept - Zagazig University | Samah Lutfy | Tropical Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, 44519, Egypt | Zagazig | zagazig U | Zagazig University | zagazig university faculty of human medicine | Zagazig University, Faculty of human medicine | Zagazig university-faculty of medicine | zagazig university hospital

Active Ingredients

Drugs in Phase 4 Trials (13)

bisoprolol (zebeta) (1 trial)

dexmedetomidine (precedex) (14 trials)

gabapentin (neurontin) (1 trial)

ketamine (ketalar) (8 trials)

ketofol (1 trial)

Lactobacillus acidophilus (1 trial)

letrozole (femara) (3 trials)

levobupivacaine (chirocaine) (2 trials)

levofloxacin (levaquin) (1 trial)

milrinone (primacor) (2 trials)

propofol (diprivan) (6 trials)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

timothy grass pollen allergen extract (Grastek) (1 trial)

Drugs in Phase 3 Trials (15)

betamethasone (celestone) (1 trial)

bevacizumab (avastin) (1 trial)

birch pollen allergen extract (2 trials)

calcipotriene (dovonex) (1 trial)

ivermectin (stromectol) (2 trials)

lidocaine (xylocaine) (6 trials)

magnesium sulfate (Tis-U-Sol) (3 trials)

megesterol (1 trial)

misoprostol (cytotec) (4 trials)

petrolatum, white (Vaseline) (1 trial)

ranibizumab (lucentis) (1 trial)

rivaroxaban (xarelto) (1 trial)

ropivacaine (naropin) (1 trial)

turmeric (1 trial)

vasopressin (vasostrict) (1 trial)

Drugs in Phase 2 Trials (18)

candida antigen (1 trial)

chlorhexidine (hibitane) (1 trial)

clindamycin (cleocin) (1 trial)

esmolol (brevibloc) (1 trial)

fentanyl (Innovar) (7 trials)

hydroxychloroquine (plaquenil) (1 trial)

labetalol (trandate) (2 trials)

laminaria (1 trial)

levocarnitine (carnitor) (2 trials)

mesalamine (rowasa) (1 trial)

midazolam (versed) (3 trials)

multivitamins (1 trial)

nimodipine (nimotop) (1 trial)

pirfenidone (esbriet) (1 trial)

platelet rich plasma (3 trials)

pregabalin (lyrica) (3 trials)

sitagliptin (januvia) (2 trials)

vitamin d3 (2 trials)

Drugs in Phase 1 Trials (5)

bupivacaine (Exparel) (5 trials)

nalbuphine (nubain) (2 trials)

saccharomyces cerevisiae (1 trial)

vitamin c (1 trial)

vitamin e (1 trial)

Drugs in Other Trials (29)

acetaminophen (tylenol) (1 trial)

allogeneic blood cells (1 trial)

caffeine (1 trial)

clarithromycin (biaxin) (1 trial)

clomidazole (1 trial)

colchicine (colbenemid) (1 trial)

daclatasvir (daklinza) (2 trials)

dexamethasone (1 trial)

epinephrine (levophed) (2 trials)

furosemide (lasix) (1 trial)

hepatitis b vaccine (recombinant) (recombivax) (1 trial)

lactobacillus reuteri (1 trial)

lactoferrin (1 trial)

lepipasvir (1 trial)

meclophenoxate (1 trial)

morphine (1 trial)

omeprazole (prilosec) (1 trial)

phytoestrogens (1 trial)

prednisolone (hydeltra) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

ribavirin (virazole) (2 trials)

rifaximin (xifaxan) (1 trial)

silymarin (1 trial)

sofosbuvir (sovaldi) (3 trials)

spironolactone (aldactone) (1 trial)

tetracycline (tetrex) (1 trial)

ubiquinone (1 trial)

ursodeoxycholic acid (1 trial)

vitamin k (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Agnosia (Phase 2)

Alveolitis, Extrinsic Allergic (Phase 2)

Anxiety Disorders (Phase 2)

Apnea (Phase 4)

Communicable Diseases (Phase 4)

Emergence Delirium (Phase 1)

Endometrial Hyperplasia (Phase 3)

Endometritis (Phase 2)

Heart Diseases (Phase 4)

Helicobacter Infections (Phase 4)

Hematoma (Phase 2)

Hematoma, Subdural (Phase 2)

Hematoma, Subdural, Chronic (Phase 2)

Hernia (Phase 2)

Hyperplasia (Phase 3)

Hypersensitivity (Phase 2)

Hypertension (Phase 4)

Hypertension, Pulmonary (Phase 4)

Infections (Phase 4)

Infertility (Phase 1)

Infertility, Male (Phase 1)

Leiomyoma (Phase 3)

Necrosis (Phase 2)

Neoplasm Metastasis (Phase 2)

Pain, Postoperative (Phase 4)

Pharyngitis (Phase 3)

Pneumonia (Phase 2)

Pneumothorax (Phase 2)

Polycystic Ovary Syndrome (Phase 1)

Psoriasis (Phase 3)

Psychomotor Agitation (Phase 1)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Sleep Apnea, Obstructive (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Thrombosis (Phase 3)

Vaginal Diseases (Phase 2)

Vaginosis, Bacterial (Phase 2)

Venous Thrombosis (Phase 3)

Warts (Phase 2)

Wound Infection (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 88
  • # of Trial APIs: 80